Phospho-TOP2A (Ser1106) Antibody - #AF3729

(5)  
製品: Phospho-TOP2A (Ser1106) Antibody
カタログ: AF3729
タンパク質の説明: Rabbit polyclonal antibody to Phospho-TOP2A (Ser1106)
アプリケーション: IHC IF/ICC
反応性: Human, Mouse, Rat
分子量: 174kD(Calculated).
ユニプロット: P11388
RRID: AB_2847043

類似製品を見る>>

   サイズ 価格 在庫状況
 100ul $350 在庫あり
 200ul $450 在庫あり

リードタイム: 当日配達

For pricing and ordering contact:
お問い合わせ先
関連ダウンロード
MSDS
説明書
COA
プロトコル
WB Handbook
IHC Protocol
IF/ICC Protocol

製品説明

ソース:
Rabbit
アプリケーション:
IHC 1:50-1:200, IF/ICC 1:100-1:500
*The optimal dilutions should be determined by the end user.
*Tips:

WB: For western blot detection of denatured protein samples. IHC: For immunohistochemical detection of paraffin sections (IHC-p) or frozen sections (IHC-f) of tissue samples. IF/ICC: For immunofluorescence detection of cell samples. ELISA(peptide): For ELISA detection of antigenic peptide.

反応性:
Human,Mouse,Rat
クローナリティ:
Polyclonal
特異性:
Phospho-TOP2A (Ser1106) Antibody detects endogenous levels of TOP2A only when phosphorylated at Ser1106.
RRID:
AB_2847043
引用形式: Affinity Biosciences Cat# AF3729, RRID:AB_2847043.
コンジュゲート:
Unconjugated.
精製:
The antibody is from purified rabbit serum by affinity purification via sequential chromatography on phospho-peptide and non-phospho-peptide affinity columns.
保存:
Rabbit IgG in phosphate buffered saline , pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol. Store at -20 °C. Stable for 12 months from date of receipt.
別名:

折りたたみ／展開

alpha isozyme; ATP hydrolyzing DNA topoisomerase II alfa; DNA gyrase; DNA topoisomerase (ATP hydrolyzing); DNA topoisomerase 2 alpha; DNA topoisomerase 2-alpha; DNA topoisomerase II 170 kD; DNA topoisomerase II alpha isozyme; DNA topoisomerase II; DNA Topoisomerase2; TOP 2A; TOP2; TOP2A; TOP2A_HUMAN; Topoisomerase DNA II alpha 170kDa; TP2A;

免疫原

免疫原:

A synthesized peptide derived from human TOP2A around the phosphorylation site of Ser1106.

Uniprot:

P11388(TOP2A_HUMAN) >>Visit HPA database.

遺伝子(ID):
TOP2A(7153)
タンパク質配列:
MEVSPLQPVNENMQVNKIKKNEDAKKRLSVERIYQKKTQLEHILLRPDTYIGSVELVTQQMWVYDEDVGINYREVTFVPGLYKIFDEILVNAADNKQRDPKMSCIRVTIDPENNLISIWNNGKGIPVVEHKVEKMYVPALIFGQLLTSSNYDDDEKKVTGGRNGYGAKLCNIFSTKFTVETASREYKKMFKQTWMDNMGRAGEMELKPFNGEDYTCITFQPDLSKFKMQSLDKDIVALMVRRAYDIAGSTKDVKVFLNGNKLPVKGFRSYVDMYLKDKLDETGNSLKVIHEQVNHRWEVCLTMSEKGFQQISFVNSIATSKGGRHVDYVADQIVTKLVDVVKKKNKGGVAVKAHQVKNHMWIFVNALIENPTFDSQTKENMTLQPKSFGSTCQLSEKFIKAAIGCGIVESILNWVKFKAQVQLNKKCSAVKHNRIKGIPKLDDANDAGGRNSTECTLILTEGDSAKTLAVSGLGVVGRDKYGVFPLRGKILNVREASHKQIMENAEINNIIKIVGLQYKKNYEDEDSLKTLRYGKIMIMTDQDQDGSHIKGLLINFIHHNWPSLLRHRFLEEFITPIVKVSKNKQEMAFYSLPEFEEWKSSTPNHKKWKVKYYKGLGTSTSKEAKEYFADMKRHRIQFKYSGPEDDAAISLAFSKKQIDDRKEWLTNFMEDRRQRKLLGLPEDYLYGQTTTYLTYNDFINKELILFSNSDNERSIPSMVDGLKPGQRKVLFTCFKRNDKREVKVAQLAGSVAEMSSYHHGEMSLMMTIINLAQNFVGSNNLNLLQPIGQFGTRLHGGKDSASPRYIFTMLSSLARLLFPPKDDHTLKFLYDDNQRVEPEWYIPIIPMVLINGAEGIGTGWSCKIPNFDVREIVNNIRRLMDGEEPLPMLPSYKNFKGTIEELAPNQYVISGEVAILNSTTIEISELPVRTWTQTYKEQVLEPMLNGTEKTPPLITDYREYHTDTTVKFVVKMTEEKLAEAERVGLHKVFKLQTSLTCNSMVLFDHVGCLKKYDTVLDILRDFFELRLKYYGLRKEWLLGMLGAESAKLNNQARFILEKIDGKIIIENKPKKELIKVLIQRGYDSDPVKAWKEAQQKVPDEEENEESDNEKETEKSDSVTDSGPTFNYLLDMPLWYLTKEKKDELCRLRNEKEQELDTLKRKSPSDLWKEDLATFIEELEAVEAKEKQDEQVGLPGKGGKAKGKKTQMAEVLPSPRGQRVIPRITIEMKAEAEKKNKKKIKNENTEGSPQEDGVELEGLKQRLEKKQKREPGTKTKKQTTLAFKPIKKGKKRNPWSDSESDRSSDESNFDVPPRETEPRRAATKTKFTMDLDSDEDFSDFDEKTDDEDFVPSDASPPKTKTSPKLSNKELKPQKSVVSDLEADDVKGSVPLSSSPPATHFPDETEITNPVPKKNVTVKKTAAKSQSSTSTTGAKKRAAPKGTKRDPALNSGVSQKPDPAKTKNRRKRKPSTSDDSDSNFEKIVSKAVTSKKSKGESDDFHMDFDSAVAPRAKSVRAKKPIKYLEESDEDDLF

PTMs - P11388 基板として

Site PTM Type Enzyme
M1 Acetylation
S4 Phosphorylation
S29 Phosphorylation P05129 (PRKCG) , P05771 (PRKCB)
Y82 Phosphorylation
K96 Ubiquitination
K101 Ubiquitination
K123 Ubiquitination
K131 Sumoylation
K131 Ubiquitination
Y151 Phosphorylation
K156 Ubiquitination
K157 Ubiquitination
K168 Ubiquitination
K191 Ubiquitination
K225 Ubiquitination
K227 Sumoylation
K227 Ubiquitination
S230 Phosphorylation
K233 Ubiquitination
S249 Phosphorylation
T250 Phosphorylation
K251 Ubiquitination
K254 Acetylation
K261 Ubiquitination
K265 Ubiquitination
K276 Ubiquitination
K278 Sumoylation
K278 Ubiquitination
T282 Phosphorylation
S285 Phosphorylation
K287 Ubiquitination
S312 Phosphorylation
K321 Ubiquitination
Y328 Phosphorylation
K336 Ubiquitination
K342 Ubiquitination
K352 Ubiquitination
K386 Sumoylation
K386 Ubiquitination
K397 Acetylation
K397 Ubiquitination
K418 Ubiquitination
K425 Ubiquitination
K431 Ubiquitination
K440 Sumoylation
K440 Ubiquitination
S452 Phosphorylation
C455 S-Nitrosylation
S464 Phosphorylation
K466 Ubiquitination
S471 Phosphorylation
K480 Ubiquitination
K489 Sumoylation
K489 Ubiquitination
K499 Ubiquitination
K512 Ubiquitination
Y518 Phosphorylation
K519 Ubiquitination
K520 Ubiquitination
Y522 Phosphorylation
K529 Ubiquitination
K535 Ubiquitination
K579 Ubiquitination
K584 Ubiquitination
K599 Sumoylation
K599 Ubiquitination
Y612 Phosphorylation
K614 Ubiquitination
K622 Ubiquitination
K625 Sumoylation
K625 Ubiquitination
K632 Sumoylation
K632 Ubiquitination
K639 Methylation
K639 Sumoylation
K639 Ubiquitination
K655 Ubiquitination
K656 Ubiquitination
K662 Sumoylation
K662 Ubiquitination
R672 Methylation
K676 Sumoylation
K676 Ubiquitination
S707 Phosphorylation
S709 Phosphorylation
S714 Phosphorylation
S717 Phosphorylation
K723 Ubiquitination
K728 Ubiquitination
K735 Ubiquitination
Y805 Phosphorylation
T825 Phosphorylation
K827 Ubiquitination
Y830 Phosphorylation
K893 Ubiquitination
T898 Phosphorylation
K936 Methylation
K936 Ubiquitination
K949 Ubiquitination
K967 Ubiquitination
K971 Acetylation
K971 Ubiquitination
K976 Ubiquitination
K987 Ubiquitination
K1011 Ubiquitination
R1026 Methylation
K1028 Ubiquitination
S1045 Phosphorylation
K1047 Ubiquitination
K1058 Ubiquitination
K1062 Ubiquitination
K1068 Ubiquitination
K1070 Ubiquitination
K1075 Sumoylation
K1075 Ubiquitination
K1088 Ubiquitination
S1106 Phosphorylation
T1112 Phosphorylation
K1114 Ubiquitination
T1119 Phosphorylation
K1151 Ubiquitination
T1157 Phosphorylation
K1159 Ubiquitination
S1162 Phosphorylation
S1164 Phosphorylation
K1184 Ubiquitination
K1186 Ubiquitination
K1196 Acetylation
K1196 Sumoylation
K1196 Ubiquitination
K1199 Acetylation
K1201 Acetylation
K1204 Sumoylation
K1204 Ubiquitination
T1205 Phosphorylation
S1213 Phosphorylation P28482 (MAPK1) , P27361 (MAPK3) , P06493 (CDK1)
K1228 Sumoylation
K1228 Ubiquitination
K1233 Acetylation
K1234 Acetylation
K1237 Acetylation
K1240 Sumoylation
K1240 Ubiquitination
T1244 Phosphorylation
S1247 Phosphorylation P27361 (MAPK3) , P28482 (MAPK1) , P06493 (CDK1)
K1259 Ubiquitination
T1272 Phosphorylation
T1274 Phosphorylation
K1276 Acetylation
K1276 Ubiquitination
K1283 Methylation
K1287 Acetylation
K1289 Acetylation
S1295 Phosphorylation
S1297 Phosphorylation
S1299 Phosphorylation
S1302 Phosphorylation
S1303 Phosphorylation
S1306 Phosphorylation
T1324 Phosphorylation
T1327 Phosphorylation
S1332 Phosphorylation
S1337 Phosphorylation P53350 (PLK1)
T1343 Phosphorylation P68400 (CSNK2A1) , P53350 (PLK1) , Q9H4B4 (PLK3)
S1351 Phosphorylation
S1354 Phosphorylation P27361 (MAPK3) , P28482 (MAPK1) , P06493 (CDK1)
T1358 Phosphorylation
T1360 Phosphorylation
S1361 Phosphorylation P06493 (CDK1) , P28482 (MAPK1) , P27361 (MAPK3) , P49841 (GSK3B)
S1365 Phosphorylation P68400 (CSNK2A1)
K1367 Acetylation
K1367 Ubiquitination
S1374 Phosphorylation
S1377 Phosphorylation P68400 (CSNK2A1)
K1385 Sumoylation
K1385 Ubiquitination
S1387 Phosphorylation
S1391 Phosphorylation
S1392 Phosphorylation
S1393 Phosphorylation P06493 (CDK1) , P28482 (MAPK1) , P27361 (MAPK3)
T1397 Phosphorylation
T1403 Phosphorylation
T1406 Phosphorylation
K1422 Ubiquitination
S1426 Phosphorylation
T1429 Phosphorylation
T1430 Phosphorylation
K1442 Sumoylation
K1442 Ubiquitination
R1443 Methylation
S1449 Phosphorylation
S1452 Phosphorylation
K1454 Acetylation
K1454 Ubiquitination
K1459 Ubiquitination
K1461 Ubiquitination
K1467 Acetylation
S1469 Phosphorylation P68400 (CSNK2A1)
T1470 Phosphorylation
S1471 Phosphorylation
S1474 Phosphorylation
S1476 Phosphorylation
K1480 Acetylation
K1484 Ubiquitination
S1491 Phosphorylation
K1492 Sumoylation
K1492 Ubiquitination
S1495 Phosphorylation
S1504 Phosphorylation
Y1521 Phosphorylation
S1525 Phosphorylation P68400 (CSNK2A1) , P53350 (PLK1) , P53778 (MAPK12)

研究背景

機能:

Control of topological states of DNA by transient breakage and subsequent rejoining of DNA strands. Topoisomerase II makes double-strand breaks. Essential during mitosis and meiosis for proper segregation of daughter chromosomes. May play a role in regulating the period length of ARNTL/BMAL1 transcriptional oscillation (By similarity).

PTMs:

Phosphorylation has no effect on catalytic activity. However, phosphorylation at Ser-1106 by CSNK1D/CK1 promotes DNA cleavable complex formation.

細胞の位置付け:

Cytoplasm. Nucleus>Nucleoplasm.
Note: Generally located in the nucleoplasm.

Extracellular region or secreted Cytosol Plasma membrane Cytoskeleton Lysosome Endosome Peroxisome ER Golgi apparatus Nucleus Mitochondrion Manual annotation Automatic computational assertionSubcellular location
サブユニット構造:

Homodimer. Interacts with COPS5. Interacts with RECQL5; this stimulates DNA decatenation. Interacts with SETMAR; stimulates the topoisomerase activity. Interacts with DHX9; this interaction occurs in a E2 enzyme UBE2I- and RNA-dependent manner, negatively regulates DHX9-mediated double-stranded DNA and RNA duplex helicase activity and stimulates TOP2A-mediated supercoiled DNA relaxation activity. Interacts with HNRNPU (via C-terminus); this interaction protects the topoisomerase TOP2A from degradation and positively regulates the relaxation of supercoiled DNA in a RNA-dependent manner (By similarity). Interacts with MCM3AP isoform GANP. Interacts with ERCC6.

タンパク質ファミリー:

The N-terminus has several structural domains; the ATPase domain (about residues 1-265), the transducer domain (about 266-428) and the toprim domain (455-572) (PubMed:25202966). Comparing different structures shows ATP hydrolysis induces domain shifts in the N-terminus that are probably part of the mechanism of DNA cleavage and rejoining (PubMed:25202966).

Belongs to the type II topoisomerase family.

研究領域

· Human Diseases > Drug resistance: Antineoplastic > Platinum drug resistance.

Restrictive clause

 

Affinity Biosciences tests all products strictly. Citations are provided as a resource for additional applications that have not been validated by Affinity Biosciences. Please choose the appropriate format for each application and consult Materials and Methods sections for additional details about the use of any product in these publications.

For Research Use Only.
Not for use in diagnostic or therapeutic procedures. Not for resale. Not for distribution without written consent. Affinity Biosciences will not be held responsible for patent infringement or other violations that may occur with the use of our products. Affinity Biosciences, Affinity Biosciences Logo and all other trademarks are the property of Affinity Biosciences LTD.